Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury

NCT05735093 is registered in ClinicalTrials.gov with Kırıkkale University as lead sponsor.

NCT NCT05735093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05735093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
Lead sponsor
Kırıkkale University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2023
Completion date
February 1, 2024
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury